Invesco Biotechnology & Genome ETF
Open-end / ETFRegistrant
Invesco Exchange-Traded Fund Trust
Class ticker
Net Assets
$281,946,188
Holdings
33
Latest Report
Jul 31, 2026
Net Assets Over Time
Holdings · 33
Export CSV| Holding | Symbol | Balance | Value | % of Fund | Side | Category | Open |
|---|---|---|---|---|---|---|---|
|
Invesco Private Prime Fund
|
— | 36,338,961 | $36,342,595 | 12.89% | Long | STIV | |
| Regeneron Pharmaceuticals, Inc. | REGN | 20,233 | $15,430,293 | 5.47% | Long | EC | |
| Amgen Inc. | AMGN | 38,223 | $14,721,971 | 5.22% | Long | EC | |
| CareDx, Inc. | CDNA | 325,179 | $14,213,574 | 5.04% | Long | EC | |
| Vertex Pharmaceuticals Inc. | VRTX | 29,460 | $14,055,366 | 4.99% | Long | EC | |
|
Invesco Private Government Fund
|
— | 14,001,686 | $14,001,686 | 4.97% | Long | STIV | |
| Royalty Pharma PLC | RPRX | 238,422 | $13,930,997 | 4.94% | Long | EC | |
| Biogen Inc. | BIIB | 66,507 | $13,497,596 | 4.79% | Long | EC | |
| Gilead Sciences, Inc. | GILD | 96,026 | $12,503,545 | 4.43% | Long | EC | |
| United Therapeutics Corp. | UTHR | 22,197 | $11,491,609 | 4.08% | Long | EC | |
| Bio-Techne Corp. | TECH | 146,019 | $10,526,510 | 3.73% | Long | EC | |
| Illumina, Inc. | ILMN | 48,231 | $9,892,178 | 3.51% | Long | EC | |
| Protagonist Therapeutics, Inc. | PTGX | 70,055 | $9,572,315 | 3.40% | Long | EC | |
| Vericel Corp. | VCEL | 200,298 | $9,205,696 | 3.27% | Long | EC | |
| Alnylam Pharmaceuticals, Inc. | ALNY | 43,457 | $8,931,283 | 3.17% | Long | EC | |
| Incyte Corp. | INCY | 72,136 | $8,621,695 | 3.06% | Long | EC | |
| Repligen Corp. | RGEN | 60,807 | $8,574,395 | 3.04% | Long | EC | |
| Acadia Pharmaceuticals Inc. | ACAD | 329,464 | $8,523,234 | 3.02% | Long | EC | |
| Halozyme Therapeutics, Inc. | HALO | 101,929 | $8,413,220 | 2.98% | Long | EC | |
| Qiagen N.V. | QGEN | 197,087 | $8,159,417 | 2.89% | Long | EC | |
| BioMarin Pharmaceutical Inc. | BMRN | 132,461 | $7,950,309 | 2.82% | Long | EC | |
| Neurocrine Biosciences, Inc. | NBIX | 44,979 | $7,502,497 | 2.66% | Long | EC | |
| Exelixis, Inc. | EXEL | 140,144 | $7,431,836 | 2.64% | Long | EC | |
| BioCryst Pharmaceuticals, Inc. | BCRX | 826,963 | $7,426,128 | 2.63% | Long | EC | |
| Veracyte, Inc. | VCYT | 158,435 | $7,338,709 | 2.60% | Long | EC | |
| Collegium Pharmaceutical, Inc. | COLL | 207,352 | $7,338,187 | 2.60% | Long | EC | |
| Omeros Corp. | OMER | 601,237 | $7,118,646 | 2.52% | Long | EC | |
| PTC Therapeutics, Inc. | PTCT | 103,541 | $7,041,823 | 2.50% | Long | EC | |
| AnaptysBio, Inc. | ANAB | 121,247 | $6,469,740 | 2.29% | Long | EC | |
| Sarepta Therapeutics, Inc. | SRPT | 420,180 | $6,243,875 | 2.21% | Long | EC | |
| Ardelyx, Inc. | ARDX | 1,120,704 | $5,547,485 | 1.97% | Long | EC | |
| Legend Biotech Corp. | LEGN | 237,196 | $4,399,986 | 1.56% | Long | EC | |
|
Invesco Government & Agency Portfolio
|
825252885 | 215,965 | $215,965 | 0.08% | Long | STIV |